Merck Q3 Non-GAAP Earnings Fall, Revenue Increases; 2026 Non-GAAP EPS Guidance Raised

07:02 AM EDT, 10/29/2026 (MT Newswires) -- Merck (MRK) reported Q3 non-GAAP earnings Thursday of $2.49 per diluted share, down from $2.58 a year earlier. Analysts polled by FactSet expected $2.09. Sales for the quarter ended Sept. 30 were $18.09 billion, up from $17.28 billion a year earlier. Analysts expected $17.33 billion. For 2026, the company raised its non-GAAP EPS projection to between $2.77 and $2.82 per share, from $2.66 to $2.76, and narrowed sales guidance to between $66.8 billion and $67.3 billion, compared with its previous forecast of $66.3 billion to $67.3 billion. Analysts expect $2.63 and $67.02 billion. Shares of the company were up 2% in recent premarket activity.